Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience

[1]  Gemma Escribano,et al.  Severe Ovarian Hyperstimulation Syndrome After Gonadotropin-Releasing Hormone (Gnrh) Agonist Trigger And ''Freeze-All'' Approach In Gnrh Antagonist Protocol , 2015 .

[2]  R. Machtinger,et al.  Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation? , 2014, Fertility and sterility.

[3]  P. Devroey,et al.  Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol. , 2014, Fertility and sterility.

[4]  M. Haadsma,et al.  Effectiveness of indometacin to prevent ovulation in modified natural-cycle IVF: a randomized controlled trial. , 2013, Reproductive biomedicine online.

[5]  B. Ata,et al.  Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. , 2013, Human reproduction.

[6]  M. Velez,et al.  Rapid policy change to single-embryo transfer while maintaining pregnancy rates per initiated cycle. , 2013, Reproductive biomedicine online.

[7]  M. Payson,et al.  Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database. , 2010, Fertility and sterility.

[8]  H. Tournaye,et al.  Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. , 2012, Human reproduction.

[9]  A. Zini,et al.  Surgically retrieved spermatozoa versus ejaculated spermatozoa in modified natural IVF-ICSI cycles. , 2012, Reproductive biomedicine online.

[10]  D. Bodri,et al.  Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort , 2012, Reproductive Biology and Endocrinology.

[11]  D. Bodri,et al.  Short-term, low-dose, non-steroidal anti-inflammatory drug application diminishes premature ovulation in natural-cycle IVF. , 2012, Reproductive biomedicine online.

[12]  F. Bissonnette,et al.  Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders. , 2011, Fertility and sterility.

[13]  L. Gianaroli,et al.  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. , 2011, Human reproduction.

[14]  M. Sbracia,et al.  Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles. , 2009, Fertility and sterility.

[15]  P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. , 2009, Reproductive biomedicine online.

[16]  O. Kato,et al.  Natural IVF cycles may be desirable for women with repeated failures by stimulated IVF cycles , 2008, Journal of Assisted Reproduction and Genetics.

[17]  B. Couturier,et al.  Spontaneous ovulation rate before oocyte retrieval in modified natural cycle IVF with and without indomethacin. , 2008, Reproductive biomedicine online.

[18]  S. Hamamah,et al.  Le cycle naturel en fécondation in vitro chez les mauvaises répondeuses , 2007 .

[19]  M. Pelinck,et al.  Cumulative pregnancy rates after a maximum of nine cycles of modified natural cycle IVF and analysis of patient drop-out: a cohort study. , 2004, Human reproduction.

[20]  B. Couturier,et al.  Controlled natural cycle IVF: experience in a world of stimulation. , 2007, Reproductive biomedicine online.

[21]  S. Hamamah,et al.  [Natural cycle in vitro fertilization cycle in poor responders]. , 2007, Gynecologie, obstetrique & fertilite.

[22]  M. Pelinck,et al.  Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study. , 2006, Human reproduction.

[23]  R. Fanchin,et al.  In vitro fertilization and embryo transfer in seminatural cycles for patients with ovarian aging. , 2005, Fertility and sterility.

[24]  M. Pelinck,et al.  Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study. , 2005, Human reproduction.

[25]  N. Frydman,et al.  La place du cycle semi-naturel dans la prise en charge de patientes ayant un mauvais pronostic en fécondation in vitro , 2004 .

[26]  C. Aragona,et al.  A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. , 2004, Fertility and sterility.

[27]  N. Frydman,et al.  [The role of the semi natural cycle as option of treatment of patients with a poor prognosis for successful in vitro fertilization]. , 2004, Journal de gynecologie, obstetrique et biologie de la reproduction.

[28]  M. Pelinck,et al.  Efficacy of natural cycle IVF: a review of the literature. , 2002, Human reproduction update.

[29]  R. Storeng,et al.  Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility. , 2001, Human reproduction.

[30]  J. Donnez,et al.  Outcome of in-vitro fertilization through natural cycles in poor responders. , 1999, Human reproduction.

[31]  R. Fanchin,et al.  Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. , 1999, Human reproduction.

[32]  H. Burger,et al.  Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition. , 1991, The Journal of clinical endocrinology and metabolism.